OKYO Net Income Per E B T from 2010 to 2025
| OKYO Stock | USD 1.10 0.03 2.80% |
Check OKYO Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OKYO Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . OKYO financial statements analysis is a perfect complement when working with OKYO Pharma Valuation or Volatility modules.
OKYO |
About OKYO Pharma Financial Statements
OKYO Pharma investors utilize fundamental indicators, such as Net Income Per E B T, to predict how OKYO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom. Okyo Pharma is traded on NASDAQ Exchange in the United States.
Check out the analysis of OKYO Pharma Correlation against competitors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OKYO Pharma. If investors know OKYO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OKYO Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OKYO Pharma is measured differently than its book value, which is the value of OKYO that is recorded on the company's balance sheet. Investors also form their own opinion of OKYO Pharma's value that differs from its market value or its book value, called intrinsic value, which is OKYO Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OKYO Pharma's market value can be influenced by many factors that don't directly affect OKYO Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OKYO Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if OKYO Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OKYO Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.